Business
Scientist Working With Premier Biomedical Invited To Present Possible Breakthrough Findings on Chemotherapy Treatment at San Antonio Breast Cancer Symposium Educational Session
Scientist Working With Premier Biomedical Invited To Present Possible Breakthrough Findings on Chemotherapy Treatment at San Antonio Breast Cancer Symposium Educational Session.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n \n Premier Biomedical, Inc. (OTCQB:BIEI) \n a biotech research company focused on discovering, developing, and \n commercializing medical treatments for a wide range of diseases in \n humans, including innovative therapies for breast cancer, announced \n today that one of the lead outside scientists working on their sponsored \n research has been invited to present his findings on the treatment of \n breast cancer, at an evening educational session sponsored by prIME \n Oncology, at the San Antonio Breast Cancer Symposium December 9, 2015.\n \n\nThis Smart News Release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20151208005481/en/\n\n\n \n Researchers have previously presented positive results from the \n application of breast cancer antibodies along with Premier Biomedical’s \n technology in duplicated testing on mice at the American Association for \n Cancer Research annual meeting in San Diego in April, 2014. These \n results showed statistically significant improvements in survival and \n prevention of breast cancer in mice treated with innovative anti-breast \n cancer treatment versus chemotherapy-only and non-treated groups. Most \n significantly, the research has shown the prevention of breast cancer \n metastasis in mice with the jointly developed breast cancer antibody.\n \n \n William A. Hartman, President and CEO of Premier Biomedical stated, “We \n have always believed we were working with leading researchers in the \n field of breast cancer treatment. This invitation to present the \n underpinnings of that work at this educational session during the San \n Antonio Breast Cancer Symposium is an indication that our beliefs were \n well founded. Our research has already led to a patent-pending breast \n cancer antibody which has been demonstrated to be approximately three \n times more effective than the successful antibody we previously \n presented to the American Association for Cancer Research Symposium in \n April, 2014. We are extremely excited to have found what we consider to \n be a huge anti-breast cancer breakthrough.”\n \n \n Mr. Hartman can be contacted via email at [email protected] \n or by phone at (PBI) MED-7033 / (724) 633-7033.\n \n \n About Premier Biomedical, Inc.\n \n \n Premier Biomedical, Inc. (OTCQB: \n BIEI) is a r...